Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
duloxetine hydrochloride, Quantity: 33.65 mg (Equivalent: duloxetine, Qty 30 mg)
Dr Reddys Laboratories Australia Pty Ltd
Duloxetine hydrochloride
Capsule, enteric
Excipient Ingredients: triethyl citrate; glycine; purified talc; hypromellose; sucrose; hypromellose phthalate; maize starch; titanium dioxide; brilliant blue FCF; purified water; allura red AC; Gelatin; acetic acid; silicon dioxide; sodium lauryl sulfate; citric acid; propylene glycol; butan-1-ol; ethanol; isopropyl alcohol; iron oxide yellow; Shellac; strong ammonia solution
Oral
10's, 28's, 7's, 14's
(S4) Prescription Only Medicine
Indications,1. Treatment of major depressive disorder (MDD),2. Treatment of diabetic peripheral neuropathic pain (DPNP),3. Treatment of generalised anxiety disorder (GAD)
Visual Identification: Size '3' hard gelatin capsule with opaque blue coloured cap and opaque white body, imprinted 'RDY609' on cap and '30 mg' on body with golden yellow ink; Container Type: Blister Pack; Container Material: PA/Al/PVC/Al - polyamide-aluminium foil-polyvinylchloride/aluminium foil; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius
Licence status A
2014-06-19